XML 46 R32.htm IDEA: XBRL DOCUMENT v3.7.0.1
Stockholders' Equity (Tables)
12 Months Ended
Dec. 31, 2016
Stockholders' Equity Note [Abstract]  
Schedule of stock options

A summary of option transactions for all of the Company’s equity plans during the years ended December 31, 2016 and 2015 follows:

 

    Number of Stock
Options
    Weighted
Average
Exercise Price
 
Outstanding at December 31, 2014     231,941       81.15  
Granted     -       -  
Exercised     -       -  
Expired/cancelled     (81,803 )     74.27  
Outstanding at December 31, 2015     150,138     $ 67.99  
Granted     -       -  
Exercised     -       -  
Expired/cancelled     (15,988 )     82.26  
Outstanding at December 31, 2016     134,150     $ 85.22  
Exercisable at December 31, 2016     109,066     $ 84.40  
Schedule of outstanding and exercisable options

The outstanding and exercisable options at December 31, 2016, have a range of exercise prices and associated weighted remaining contractual life and weighted average exercise price, as follows:

 

Options Range
of Exercise
Prices
  Outstanding
Number of
Shares
    Weighted Average
Remaining
Contractual Life
(years)
    Weighted
Average
Exercise Price
    Exercisable
Number of
Shares
    Exercisable
Weighted Avg.
Exercise Price
 
$0      -   $37.50     2,168       2.54     $ 30.78       2,168     $ 30.78  
$37.51 - $75.00     57,145       5.56     $ 71.32       47,746     $ 71.12  
$75.01-$112.50     74,640       5.38     $ 97.05       58,841     $ 96.25  
$112.51 - up     197       0.01     $ 234.06       311     $ 256.15  
Total     134,150             $ 85.22       109,066     $ 84.40  
Schedule of expiration of outstanding options

The outstanding options will expire, as follows:

 

Year Ending   Number of Options     Weighted
Average
Exercise Price
    Exercise Price  
                   
2017     197     $ 234.06       $233.10 - $239.40  
2018     -       -       -  
2019     1,954     $ 32.01       $31.20 - $44.40  
2020     534     $ 32.81       $28.50 - $40.00  
2021 and later     131,465     $ 86.00       $70.00 - $100.00  
      134,150     $ 85.22       $28.50 - $239.40  
Schedule of nonvested restricted stock

The Company has nonvested restricted stock, as follows:

 

    Share     Weighted
Average
Grant-Date
Fair Value
 
Nonvested at December 31, 2014     167,040     $ 21.60  
Granted     299,000       9.25  
Vested/cancelled     (207,468 )     17.75  
Nonvested at December 31, 2015     258,572     $ 10.55  
Granted     -       -  
Vested/cancelled     (129,361 )     10.04  
Nonvested at December 31, 2016     129,250     $ 11.07  
Schedule of warrant

A summary of warrant transactions for the years ended December 31, 2016and 2015 follows:

 

    Number of Warrants     Weighted
Average
Exercise Price
 
Outstanding at December 31, 2014     70,950       18.05  
Issued     -       -  
Exercised     -       -  
Expired/cancelled     6,450       85.95  
Outstanding at December 31, 2015     64,500       11.25  
Issued     -       -  
Exercised     -       -  
Expired/cancelled     -       -  
Outstanding at December 31, 2016     64,500     $ 11.25  
Schdule of expiration of outstanding warrants

the outstanding warrants will expire as follows:

 

Year Ending December 31,   Number of Warrants     Weighted
Average
Exercise Price
 
                 
2017     64,500       11.25  
      64,500     $ 11.25